+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Uveitis"

Uveitis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Uveitis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
From
From
From
From
From
From
Uveitis Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Uveitis Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 204 Pages
  • Global
From
Glaucoma Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Glaucoma Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 360 Pages
  • Global
From
From
From
From
From
From
From
From
From
United Arab Emirates Retinal Biologics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United Arab Emirates Retinal Biologics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • January 2024
  • 80 Pages
  • United Arab Emirates United Arab Emirates
From
Loading Indicator

Uveitis is a medical condition that affects the uvea, the middle layer of the eye. It is characterized by inflammation of the uvea, which can lead to vision loss and other complications. In the context of optical, uveitis is a major cause of vision loss and can be treated with a variety of treatments, including topical and systemic medications, laser treatments, and surgery. Uveitis is a growing market in the optical industry, as it is a common cause of vision loss and can be treated with a variety of treatments. Companies in the uveitis market include Bausch + Lomb, Novartis, Allergan, and Santen Pharmaceuticals. These companies offer a range of treatments for uveitis, including topical and systemic medications, laser treatments, and surgery. Show Less Read more